CIK 0001832038
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851403134
- Phone
- +1 781-819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-10 | MITHRIL II LP 10% owner | Conversion | +9,244,580 | 9,244,580 | ||
| 2021-08-10 | MITHRIL II LP 10% owner | Purchase | +1,997,000 | $17.00 | $33.9M | 11,241,580 |
| 2021-08-10 | MITHRIL II LP 10% owner | Conversion · Series A Preferred Stock | −1,250,000 | 0 | ||
| 2021-08-10 | MITHRIL II LP 10% owner | Conversion · Series B Preferred Stock | −176,304 | 0 | ||
| 2021-08-10 | MITHRIL II LP 10% owner | Conversion · Series C Preferred Stock | −422,612 | 0 |
Page 1 of 1 · 5 trades